Show Summary Details
Page of

Haemodialysis in the critically ill 

Haemodialysis in the critically ill
Chapter:
Haemodialysis in the critically ill
Author(s):

Rolando Claure-Del Granado

and Ravindra L. Mehta

DOI:
10.1093/med/9780199600830.003.0215
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 October 2020

Haemodialysis was the first method available to treat patients with kidney failure and remains an important treatment for critically-ill patients with acute kidney injury. Recent studies have shown that intermittent haemodialysis, sustained low-efficiency dialysis, and continuous renal replacement therapies provide similar outcomes for intensive care unit patients. Haemodialysis techniques offer several advantages—informed decisions regarding choice of mode require consideration of the operational characteristics of each method with its advantages and limitations. The choice of modality should be driven by patient characteristics and clinical scenario, ensuring that an adequate delivered dose of dialysis is achieved and there is good haemodynamic tolerance to minimize further insults to the kidney and other organs. This chapter reviews the current concepts and controversies in haemodialysis methods for renal support in the ICU.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.